Every Form 4 that FLEX LNG Ltd. (FLNG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow FLNG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FLNG filings page.
Flex LNG Ltd. (FLNG) reports that Chief Executive Officer Foss Halfdan Marius exercised 27,575 vested cash-settled synthetic options on August 20, 2026 under the issuer's Synthetic Option Scheme. The cash settlement was based on the $32.48 NYSE closing price on August 19, 2026 minus the $20.75 strike price per synthetic share option. No ordinary shares were issued upon exercise. Following this transaction, he held 167,042 synthetic options, which are cash-settled instruments and do not represent rights to acquire ordinary shares.
Flex LNG Ltd. reported that Chief Executive Officer Halfdan Marius Foss received a grant of 111,893 cash-settled synthetic options under the company’s Synthetic Option Scheme. These compensation awards were granted at no cost, with an initial exercise price of $30.00 per option.
The options vest in three equal annual installments on June 24, 2027, June 24, 2028, and June 24, 2029, and expire on June 24, 2031. Following this award, Foss holds 194,617 synthetic options. These instruments are cash-settled and do not represent rights to acquire ordinary shares.
Flex LNG Ltd. Chief Financial Officer Knut Traaholt received a grant of 83,919 cash-settled synthetic options under the company’s Synthetic Option Scheme. These derivative awards were granted without any cash payment from him and carry an initial exercise price of $30.00 per option.
The options vest in three equal annual installments on June 24, 2027, June 24, 2028, and June 24, 2029, and expire on June 24, 2031. After this grant, Traaholt holds a total of 144,962 synthetic options. The reported instruments are cash-settled and do not provide a right to acquire ordinary shares.